Literature DB >> 14650373

Drug disposition analysis: a comparison between budesonide and fluticasone.

Anders Källén1, Lars Thorsson.   

Abstract

The characterisation of distribution and elimination properties of a drug is usually done using parameters like clearance and distributional volumes. To refine this characterisation, in this paper, we use drug disposition analysis to compare the distribution and elimination of the two glucocorticosteroids budesonide and fluticasone propionate, known to differ in this respect. This gives a more detailed description of the well known differences in distributional volumes using concepts like mean residence time and fraction of dose outside the central compartment. It clearly shows that fluticasone, although having lower plasma concentrations, still resides in the body in appreciable quantities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14650373     DOI: 10.1023/a:1026123317752

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  10 in total

1.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

2.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

Review 3.  Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids.

Authors:  M Johnson
Journal:  J Allergy Clin Immunol       Date:  1996-01       Impact factor: 10.793

4.  Some general estimation methods for nonlinear mixed-effects models.

Authors:  M Davidian; D M Giltinan
Journal:  J Biopharm Stat       Date:  1993-03       Impact factor: 1.051

5.  Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI.

Authors:  L Thorsson; S Edsbäcker; T B Conradson
Journal:  Eur Respir J       Date:  1994-10       Impact factor: 16.671

6.  Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. I. Derivations and theoretical analysis.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

7.  Population pharmacokinetic data and parameter estimation based on their first two statistical moments.

Authors:  S L Beal
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

8.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics.

Authors:  W R Gillespie; P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1985-08

9.  Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.

Authors:  L Thorsson; S Edsbäcker; A Källén; C G Löfdahl
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

10.  Pharmacokinetics of intravenous fluticasone propionate in healthy subjects.

Authors:  A E Mackie; G P Ventresca; R W Fuller; A Bye
Journal:  Br J Clin Pharmacol       Date:  1996-06       Impact factor: 4.335

  10 in total
  1 in total

1.  A pharmacokinetic simulation tool for inhaled corticosteroids.

Authors:  Benjamin Weber; Guenther Hochhaus
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.